NCT05374551

Brief Summary

The goal of this study is to understand the basic brain mechanisms supporting episodic memory in healthy young adults. Transcranial magnetic stimulation will be used to influence brain activity in regions thought to be important for episodic memory. Behavioral testing and MRI will be used to measure the effects of stimulation on memory and on changes in brain network interactions, allowing us to draw causal inferences regarding the role of specific brain regions in memory processes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 16, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

October 6, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

2.2 years

First QC Date

April 29, 2022

Last Update Submit

February 24, 2026

Conditions

Keywords

cognitive neurosciencefunctional magnetic resonance imagingtranscranial magnetic stimulation

Outcome Measures

Primary Outcomes (2)

  • Accuracy on tests of episodic memory

    Participants will complete tasks where they encode and retrieve events. Episodic memory quality will be assessed as the accuracy with which they can recall scene details associated with each event.

    Tasks will be completed during the hour following stimulation.

  • Task-related functional connectivity among posterior medial brain regions

    Psychophysiological interaction analyses will be used to assess task-related functional connectivity while participants complete the memory retrieval task. This will identify interactions among brain regions that are associated with successful memory retrieval.

    Functional connectivity will be assessed during the hour following stimulation.

Study Arms (1)

All participants

OTHER

All participants will complete all experimental conditions, which include transcranial magnetic stimulation (continuous theta-burst stimulation) to a brain region of experimental interest and to a control brain region.

Other: Transcranial magnetic stimulation

Interventions

Transcranial magnetic stimulation will be used to stimulate brain activity in a brain region of experimental interest (lateral parietal cortex) and in a control brain region (vertex). All participants will experience both forms of stimulation, in separate sessions. Stimulation will be applied as a probe to understand the basic phenomenon of how brain processes support episodic memory.

Also known as: Continuous theta-burst stimulation
All participants

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 18 to 35 years old
  • Fluent in English
  • Free of major neurological or psychiatric illness
  • Right-handed
  • Normal or corrected to normal vision

You may not qualify if:

  • History of a psychiatric illness within the past two years
  • History of a learning disorder (e.g., attention deficit disorder, dyslexia)
  • History of neurological disorder or brain injury, including family history of epilepsy, convulsions or seizures, stroke; vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, even without a history of seizure, and without anticonvulsant medication, and any unexplained lifetime loss of consciousness/syncope
  • Use of medications that reduce seizure threshold (e.g., tricyclic antidepressants, neuroleptic agents)
  • History of neurosurgery
  • History of heart disease
  • Recreational drug use in the past two months
  • Uncontrollable shaking, or inability to sit/lie still for one hour
  • Evidence of neurological disorders or structural abnormalities, based on MRI
  • Pregnancy
  • Prior surgeries, conditions, and/or implants that are not MRI-safe, including: pacemaker, pacemaker wires, artificial heart valve, brain aneurysm surgery, middle ear implant, non-removable hearing aids, braces, or extensive dental work, implanted mechanical or electrical device, artificial limb or joint
  • Foreign metallic objects in the body, such as bullets, BBs, shrapnel, or metalwork fragments
  • History of metal work or ocular metallic foreign bodies
  • History of uncontrolled migraines or susceptibility to headaches
  • Use of centrally-acting medications and drugs, with the exception of caffeine, within the last 12 hours
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston College

Chestnut Hill, Massachusetts, 02467, United States

Location

MeSH Terms

Interventions

Transcranial Magnetic Stimulation

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2022

First Posted

May 16, 2022

Study Start

October 6, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations